Novavax says it could start making Omicron-specific vaccine in January

Go back to Novavax says it could start making Omicron-specific vaccine in January
Novavax, Inc. (NASDAQ: NVAX) Delayed: 12.56 +2.10 (20.08%)
Previous Close $10.46    52 Week High $9.23 
Open $10.47    52 Week Low $1.16 
Day High $13.39    P/E N/A 
Day Low $10.28    EPS $-0.30 
Volume 28,673,354